GENETIC CHARACTERIZATION OF ALPORT SYNDROME
阿尔波特综合征的遗传特征
基本信息
- 批准号:3239219
- 负责人:
- 金额:$ 13.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 1993-02-28
- 项目状态:已结题
- 来源:
- 关键词:DNA Goodpasture's syndrome autosomal dominant trait biopsy chromosome deletion congenital deafness gel electrophoresis genetic counseling genetic disorder genetic disorder diagnosis genetic mapping genetic markers genetic transcription genotype glomerulonephritis human population genetics kidney transplantation linkage mapping major histocompatibility complex molecular pathology nephritis nucleic acid probes nucleic acid sequence sex chromosomes skin
项目摘要
Alport syndrome (AS) denominates a heterogeneous group of
hereditary chronic progressive glomerulonephritides that are
characterized by similar nephrologic symptoms and by similar
progressive degeneration of glomerular capillary epithelial
basement membranes (GBM). The etiology of AS is unknown but
is thought to involve defects of GBM structural proteins. Disease
frequency is greater than or equal to 1 in 5,000. Most affected
males experience end-stage renal disease (ESRD), and they
account for 2-4% of males that receive dialysis or kidney
transplantation. Phenotypic heterogeneity of AS among different
kindreds includes eye defects, thrombocytopathia, and/or
progressive sensorineural deafness, and rate of progression of
renal failure. Genotypic heterogeneity is reported to include
autosomal as well as the more clearly established X-linked
inheritance. The long-term objective of this application is to
determine the genetic and biochemical bases of AS in order that
specific and effective treatments or prevention might be
developed. We propose to better define the phenotypes, and to
use linkage of nephritis to X-linked restriction fragment length
polymorphic markers (RFLPs) to precisely map the chromosomal
locus for each of three X-linked AS phenotypes found among 23
Utah kindreds. We have already shown that two types of AS
among the three largest Utah kindreds are loosely linked to DNA
probes in the middle of the long arm of the X chromosome. We
propose to construct a high-resolution genetic linkage map of this
region of the X with currently available probes and ones we plan
to develop. By mapping the AS gene(s) within this genetically
well-defined region, we expect to test the hypothesis of genetic
heterogeneity for X-linked AS, to improve the process of genetic
diagnosis and counseling for this disease, and to develop an
approach to the identification and cloning of the defective
gene(s). We also propose to determine whether X-chromosome
deletions cause AS: the existence of deletions would improve the
prospects for rapid identification of the normal gene(s) that are
missing in AS.
阿尔波特综合征(AS)是指一组不同类型的
遗传性慢性进行性肾小球肾炎
以相似的肾病症状和相似的
肾小球毛细血管上皮进行性变性
基底膜(GBM)。AS的病因尚不清楚,但
被认为与GBM结构蛋白的缺陷有关。疾病
频率大于或等于1/5,000。受影响最大的
男性患有终末期肾病(ESRD),他们
占接受透析或肾脏治疗的男性的2-4%
移植。不同亚型间AS的表型异质性
家系包括眼睛缺陷、血小板增多症和/或
进行性感音神经性耳聋和进展率
肾功能衰竭。据报道,基因异质性包括
常染色体以及更明确地建立的X连锁
继承。此应用程序的长期目标是
确定AS的遗传和生化基础,以便
具体和有效的治疗或预防可能是
发展起来的。我们建议更好地定义表型,并
利用肾炎与X-连锁限制性片段长度的连锁
用于精确定位染色体的多态标记(RFLP)
在23个X-连锁AS表型中发现了每一个的基因座
犹他州的亲戚。我们已经展示了两种类型的AS
在犹他州最大的三个家族中,与DNA的联系很松散
位于X染色体长臂中间的探针。我们
建议构建这一高分辨率的遗传连锁图谱
带当前可用的探测器和我们计划的探测器的X区域
去发展。通过将AS基因(S)定位在该基因内
定义明确的区域,我们希望检验遗传假说
针对X连锁AS的异质性,改善遗传过程
对这种疾病的诊断和咨询,并制定一种
缺陷基因的鉴定与克隆方法探讨
基因(S)。我们还建议确定X染色体是否
删除的原因是:删除的存在将改善
正常基因(S)的快速鉴定前景
在AS中失踪。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Isolation, characterization, and physical localization of 33 human X-chromosome RFLP markers.
33 个人类 X 染色体 RFLP 标记的分离、表征和物理定位。
- DOI:10.1159/000132977
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Dietz-Band,JN;Turco,AE;Willard,HF;Vincent,A;Skolnick,MH;Barker,DF
- 通讯作者:Barker,DF
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CURTIS L ATKIN其他文献
CURTIS L ATKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CURTIS L ATKIN', 18)}}的其他基金
相似海外基金
IMMUNOSUPPRESSION AND PLASMAPHERESIS IN GOODPASTURE'S SYNDROME
Goodpasture 综合征中的免疫抑制和血浆去除术
- 批准号:
4689968 - 财政年份:
- 资助金额:
$ 13.5万 - 项目类别:
IMMUNOSUPPRESSION AND PLASMAPHERESIS IN GOODPASTURE'S SYNDROME
Goodpasture 综合征中的免疫抑制和血浆去除术
- 批准号:
3964768 - 财政年份:
- 资助金额:
$ 13.5万 - 项目类别:














{{item.name}}会员




